Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes.

Xu, Chengbo; Xu, Hongfang; Liu, Baimei

Xu, Chengbo; Xu, Hongfang; Liu, Baimei.

Afiliación

Xu C; Department of Otolaryngology Head and Neck Surgery, Jinhua Wenrong Hospital, Jinhua, China.
Xu H; Department of Otolaryngology Head and Neck Surgery, Jinhua Wenrong Hospital, Jinhua, China.
Liu B; Department of Otolaryngology Head and Neck Surgery, Yongkang First People's Hospital, Yongkang, China.

PeerJ ; 11: e16364, 2023.

Article en En | MEDLINE | ID: mdl-38025757

Asunto(s)

Apoptosis; Neoplasias de Cabeza y Cuello; Humanos; Pronóstico; Antígeno CTLA-4; Carcinoma de Células Escamosas de Cabeza y Cuello/tratamiento farmacológico; Neoplasias de Cabeza y Cuello/tratamiento farmacológico; Proteínas

Palabras clave

Chemotherapy; Classification; Head and neck squamous; Immunotherapy; Prognostic signature; Programmed cell death

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Apoptosis / Neoplasias de Cabeza y Cuello Límite: Humans Idioma: En Revista: PeerJ Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google